RenovaCare, Inc., (OTCQB: RCAR), the developer of novel medical grade liquid spray devices and patented CellMist™ and SkinGun™ technologies*, released a revolutionary ‘before and after’ video that highlights the transformative treatment of severe burns by spraying a patient’s own stem cells on the affected area to rapidly heal wounds. The 90 minute procedure uses a small sample of the patient’s skin to extract stem cells needed to successfully treat burn wounds in as little as a few short days, avoiding invasive surgery, months of painful skin grafts and therapy.
Copyright © 2015 RenovaCare, Inc. Read more at: http://renovacareinc.com/2016/07/watch-remarkable-patient-recovery-using-renovacare-skingun/
About RenovaCare
RenovaCare, Inc. is developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs, and novel medical grade liquid sprayer devices. The company’s pipeline products under development target the body’s largest organ, the skin. The RenovaCare CellMist™ System will use the patented SkinGun™ to spray a liquid suspension of a patient’s stem cells – the CellMist™ Solution – onto wounds. RenovaCare is developing its CellMist™ System as a promising new alternative for patients suffering from burns, chronic and acute wounds, and scars. In the U.S. alone, this $45 billion market is greater than the spending on high-blood pressure management, cholesterol treatments, and back pain therapeutics. In addition to the SkinGun™, the company is developing a medical-grade sprayer that uses a liquid-into-air stream system to disperse a gentle spray of wound care and/or irrigation fluids over a wound area.
